News
American pharmaceutical giant MSD is scrapping the planned £1bn expansion of its operations in the UK saying the government ...
One of America’s largest drug companies has ditched plans to open a £1bn research centre in London amid a growing row with the Government over surging NHS charges.
The CORALreef Lipids trial in patients with elevated cholesterol (hypercholesterolaemia) at risk of atherosclerotic ...
Clinical Trials Arena on MSN8d
MSD’s oral PCSK9 scores Phase III hat-trick
M SD’s oral proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor has succeeded in a third Phase III trial in ...
MSD has agreed to acquire UK biopharma company Verona Pharma in a $10bn deal, strengthening its cardio-pulmonary care ...
MSD and Daiichi Sankyo have initiated the Phase III HERTHENA-Breast04 clinical trial, with the first subject receiving a dose ...
The results of the 6,105-patient VICTOR study showed that Verquvo (vericiguat) was unable to meet its objective of reducing ...
The Punch on MSN3d
Nigeria now Africa’s biggest HPV vaccine market – MSD MD
Zweli Bashman, the Managing Director of MSD for South Africa and the sub-Saharan Africa region, a global healthcare leader ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback